Replies to post #7637 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

U.S. ATryn Development Timeline

[Updated based on 1Q08 CC.]


Jun 2008: Announce US partnership for HD indication and AD indication(s).

Jul/Aug 2008: Complete BLA submission.

Sep/Oct 2008: FDA decision on priority review (approximately 60 days after BLA submission).

Jan/Feb 2009: FDA decision on BLA (assuming a six-month priority review).